Health Care: Drugs

Arqule Inc (ARQL: NASDAQ)

$1.42 -0.01 | -0.7%
07/22/14 - 10:15 AM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 15.91M 36.41M 47.31M 29.22M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 15.91M 36.41M 47.31M 29.22M
Selling, General, and Administrative Expenses 12.84M 13.85M 13.37M 13.48M
Research & Development 27.56M 33.97M 45.01M 47.03M
Operating Income before D & A (EBITDA) -24.48M -11.40M -11.07M -31.29M
Depreciation & Amortization 2.46M 2.38M 1.74M 2.56M
Interest Income 502.00K 445.00K 317.00K 619.00K
Other Income - Net 57.00K 113.00K 20.00K 266.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -27.02M -13.23M -12.47M -32.96M
Interest Expense 32.00K 26.00K 25.00K 274.00K
Pre-Tax Income -27.06M -13.26M -12.50M -33.23M
Income Taxes 0.00 0.00 0.00 -550.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -24.60M -10.87M -10.76M -30.13M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -24.60M -10.87M -10.76M -30.13M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -24.60M -10.87M -10.76M -30.13M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-23.95M -10.87M -10.76M -30.13M
Preferred Dividends
Net Income Available To Common -24.60M -10.87M -10.76M -30.13M
Basic EPS from Continuing Ops. -0.39 -0.18 -0.20 -0.68
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.39 -0.18 -0.20 -0.68
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.39 -0.18 -0.20 -0.68
Basic Normalized Net Income/Share -0.38 -0.18 -0.20 -0.68
EPS fr Continuing Ops. -0.39 -0.18 -0.20 -0.68
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.39 -0.18 -0.20 -0.68
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.39 -0.18 -0.20 -0.68
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.38 -0.18 -0.20 -0.68
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ARQL

Latest ARQL Headlines from TheStreet

More Financial News for ARQL

Press Releases for ARQL

See All Press Releases

Partner Headlines for ARQL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter